STAT+: Pharmalittle: We’re reading about a broader $35 insulin cap, a former FDA cancer drug chief, and more

STAT News

STAT+: Pharmalittle: We’re reading about a broader $35 insulin cap, a former FDA cancer drug chief, and more

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

The search for affordability wins is leading U.S. senators back to capping the cost of insulin at $35 in the private insurance market and for the uninsured ...

전문 보기

STAT+: Pharmalittle: We’re reading about a broader $35 insulin cap, a former FDA cancer drug chief, and more

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Age bias discovered in AI

What Breaks a Cell’s Ribs Can Make It Stronger

Red-tailed hawks maintain flight performance despite missing feathers

STAT의 다른 기사

What’s next for 988 LGBTQ+ services?

STAT+: Moderna co-founder Kenneth Chien on the future of mRNA — and Moderna

STAT+: Investor Clive Meanwell on designing biotechs for population health, and AI’s role as a catalyst